1. USRDS: U S Renal Data System, USRDS 2011 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2011.
2. Beathard GA, Litchfield T, Physician Operators Forum of RMS Lifeline, Inc. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int. 2004;66(4):1622–32.
3. Vachharajani TJ, Moossavi S, Salman L, et al. Dialysis vascular access management by Interventional Nephrology Programs at University Medical Centers in the United States. Semin Dial. 2011;24(5):564–9.
4. Gan TJ. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet. 2006;45(9):855–69.
5. Beathard GA, Urbanes A, Litchfield T, Weinstein A. The risk of sedation/analgesia in hemodialysis patients undergoing interventional procedures. Semin Dial. 2011;24(1):97–103.